Taiwan FDA registration 45a274e2fd50f3d133145c71c9f68d54

"Person" ASICS drug-releasing coronary bifurcation stent system

TW: “柏盛”亞瑟士藥物釋放型冠狀動脈分叉支架系統
Taiwan flagTaiwan·Risk Class 3·BIOSENSORS EUROPE SA;; BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.·Registered May 22, 2014 – May 22, 2019Cancelled
Registration details
Analysis ID
45a274e2fd50f3d133145c71c9f68d54
Customs Code
DHA05602594601
Company information
Manufacturer Country
Switzerland;;Singapore
Product details
Intended Use
For details, it is Chinese approved copy of the imitation order
Product Type (Level 1)
E Cardiovascular Medicine Science
Product Type (Level 2)
E.0001 Cardiovascular stents
Import Information
import
Dates and status
Registration Date
May 22, 2014
Expiry Date
May 22, 2019
Cancellation Date
Jun 07, 2022
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Person" ASICS drug-releasing coronary bifurcation stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 45a274e2fd50f3d133145c71c9f68d54 and manufactured by BIOSENSORS EUROPE SA;; BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.. The authorized representative in Taiwan is IDS MEDICAL SYSTEMS (HONG KONG) COMPANY LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices